663-P: Medication Adherence (MA) Is an Independent Predictor for Glycemic Control Even after Adjustment for Lifestyle Confounders in Japanese Patients with Type 2 Diabetes

The impact of MA on glycemic control may be affected by lifestyle confounders but little is known on this topic. We investigated clinical variables significantly associated with MA for OHA and the association between MA and glycemic control considering the effects of smoking, drinking alcohol, exercise and dietary habits in Japanese with DM using a large claims database. Analyzed were 6651 DM patients with medication records for OHA for at least 1 y (mean age 54 y, HbA1c 7.2%). MA was evaluated by the proportion of days covered (PDC), and PDC Disclosure Y. Yaguchi: None. K. Fujihara: None. M.H. Yamada: None. T. Sato: None. M. Kitazawa: None. M. Yamamoto: None. H. Seida: None. N. Yamanaka: None. Y. Matsubayashi: None. H. Sone: Research Support; Self; Kyowa Hakko Kirin Co., Ltd., Novartis AG, Ono Pharmaceutical Co., Ltd., Taisho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co.